| Literature DB >> 25362713 |
Ana-Maria Orbai1, Joshua Weitz2, Evan L Siegel2, Stefan Siebert2, Laura J Savage2, Sibel Z Aydin2, Jolanda J Luime2, Ori Elkayam2, Barbara Neerinckx2, Slavo Urbancek2, Kurt de Vlam2, Christopher T Ritchlin2.
Abstract
Enthesitis is a characteristic feature of psoriatic arthritis (PsA) and is important in disease pathogenesis and classification. Use of clinical outcome measures for enthesitis is heterogeneous, and only 1 measure has been specifically developed and validated in PsA. Ultrasound and magnetic resonance imaging assessments of enthesitis may have advantages over clinical examination but are insufficiently studied. As part of an update of treatment recommendations by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), we performed a systematic literature review and identified randomized controlled trials with enthesitis outcomes in PsA. For each treatment agent we calculated treatment effect sizes (where applicable) and graded the level of evidence.Entities:
Keywords: ENTHESITIS; ENTHESOPATHY; OUTCOME MEASURES; PSORIATIC ARTHRITIS; TREATMENT
Mesh:
Substances:
Year: 2014 PMID: 25362713 DOI: 10.3899/jrheum.140878
Source DB: PubMed Journal: J Rheumatol ISSN: 0315-162X Impact factor: 4.666